Zingiberen newsaponin

CAS No. 91653-50-8

Zingiberen newsaponin( Zingiberensis saponin I )

Catalog No. M29244 CAS No. 91653-50-8

Zingiberen newsaponin is a steroidal saponin from Dioscorea zingiberensis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 407 In Stock
5MG 217 In Stock
10MG 353 In Stock
25MG 550 In Stock
50MG 737 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Zingiberen newsaponin
  • Note
    Research use only, not for human use.
  • Brief Description
    Zingiberen newsaponin is a steroidal saponin from Dioscorea zingiberensis.
  • Description
    Zingiberen newsaponin is a steroidal saponin from Dioscorea zingiberensis.(In Vitro):In the screening test on platelet aggregation, Zingiberen newsaponin exhibited an induction effect on platelet aggregation in vitro.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Zingiberensis saponin I
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PARP
  • Recptor
    PARP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    91653-50-8
  • Formula Weight
    1047.195
  • Molecular Formula
    C51H82O22
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC=C5C[C@H](CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H]3O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)O[C@]11CC[C@@H](C)CO1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • PARP1/2/TNKS1/2-IN-1

    PARP1/2/TNKS1/2-IN-1 is a multi-target inhibitor of PARP-1, PARP-2, TNKS1, and TNKS2, with potential anti-tumor activity that induces apoptosis.

  • RBN012759

    RBN012759, a potent and selective PARP14 inhibitor, decreases pro-tumor macrophage function and elicits inflammatory responses in tumor explants.

  • Rucaparib Camsylate

    Rucaparib Camsylate is a PARP inhibitor (PARP1,Ki of 1.4 nM). Rucaparib Camsylate also displays binding affinity to eight other PARP domains. Rucaparib is the most effective PARP inhibitor in enzyme assays (Ki: 1.4 nM). Rucaparib inhibits PARP-1 activity by 97.1% at a concentration of 1 μM in permeabilized D283Med cells.